Research Progress on the Mechanisms of Autophagy in Hepatocellular Carcinoma

Abstract

Autophagy, a cellular breakdown process, has two distinct roles in the progression of cancer: nutrition still furthers this; it is either a hindrance or propelling to tumor growth. Autophagy is the process of recycling cellular waste and is tightly controlled at the molecular level in hepatocellular carcinoma hepatocellular carcinoma (HCC). Through the process of consideration, the mechanisms (mTOR and AMPK pathways) along with the Beclin-1/Vps34 complex are distilled. The other main thing we touch on is how the cell sees the absence of a normal covert that leads to cancer cells. Due to the recent scientific and research milestones, autophagy has been proven to have its own genes and pathways, which form its characteristic in HCC. Thus, these discoveries have addressed areas leading to the identification of novel therapeutic targets therapeutically. Moreover, in this article, the clinical ramifications of autophagy in HCC are discussed. The implications of autophagy as a predictive factor, along with identified fetters and broadening frontiers in the employment of autophagy as a potential drug for the treatment of cancer, are involved. The purpose of the research is to pinpoint the complexity of autophagy in cancer treatment scope, as well as reveal unaddressed topics and focus the effort on the improvement of cancer treatments. This is accomplished by describing the current autophagy information related to HCC and the progress achieved in autophagy research regarding HCC. This review provided an overview of what was accomplished in the autophagy research process.